# Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder

> **NCT00195598** · PHASE3 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 70 (estimated)

## Conditions studied

- Panic Disorders

## Interventions

- **DRUG:** VENLAFAXINE
- **DRUG:** Paroxetine

## Key facts

- **NCT ID:** NCT00195598
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2010-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00195598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00195598, "Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00195598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*